Icu Medical Inc (ICUI)

$98.2

-2.55

(-2.53%)

Market is closed - opens 7 PM, 15 Apr 2024

Insights on Icu Medical Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 549.31M → 587.98M (in $), with an average increase of 3.3% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 7.23M → -17.14M (in $), with an average decrease of 336.9% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 44.1% return, outperforming this stock by 88.2%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 43.5% return, outperforming this stock by 96.3%

Performance

  • $97.80
    $99.90
    $98.20
    downward going graph

    0.41%

    Downside

    Day's Volatility :2.1%

    Upside

    1.7%

    downward going graph
  • $78.28
    $212.43
    $98.20
    downward going graph

    20.29%

    Downside

    52 Weeks Volatility :63.15%

    Upside

    53.77%

    downward going graph

Returns

PeriodIcu Medical IncSector (Health Care)Index (Russel 2000)
3 Months
5.33%
-1.1%
0.0%
6 Months
-11.55%
6.7%
0.0%
1 Year
-43.69%
3.2%
-0.7%
3 Years
-52.85%
15.2%
-21.6%

Highlights

Market Capitalization
2.4B
Book Value
$87.96
Earnings Per Share (EPS)
-1.23
PEG Ratio
0.99
Wall Street Target Price
136.0
Profit Margin
-1.31%
Operating Margin TTM
-0.93%
Return On Assets TTM
0.67%
Return On Equity TTM
-1.41%
Revenue TTM
2.3B
Revenue Per Share TTM
93.78
Quarterly Revenue Growth YOY
1.7000000000000002%
Gross Profit TTM
697.8M
EBITDA
276.6M
Diluted Eps TTM
-1.23
Quarterly Earnings Growth YOY
-0.24
EPS Estimate Current Year
4.73
EPS Estimate Next Year
6.78
EPS Estimate Current Quarter
1.19
EPS Estimate Next Quarter
0.89

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Icu Medical Inc(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
7
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 38.49%

Current $98.20
Target $136.00

Company Financials

FY18Y/Y Change
Revenue
1.4B
↑ 8.31%
Net Income
28.8M
↓ 58.05%
Net Profit Margin
2.06%
↓ 3.25%
FY19Y/Y Change
Revenue
1.3B
↓ 9.56%
Net Income
101.0M
↑ 250.9%
Net Profit Margin
7.98%
↑ 5.92%
FY20Y/Y Change
Revenue
1.3B
↑ 0.38%
Net Income
86.9M
↓ 14.02%
Net Profit Margin
6.83%
↓ 1.15%
FY21Y/Y Change
Revenue
1.3B
↑ 3.56%
Net Income
103.1M
↑ 18.72%
Net Profit Margin
7.84%
↑ 1.01%
FY22Y/Y Change
Revenue
2.3B
↑ 73.21%
Net Income
-74.3M
↓ 172.03%
Net Profit Margin
-3.26%
↓ 11.1%
FY23Y/Y Change
Revenue
2.3B
↓ 0.93%
Net Income
-29.7M
↓ 60.08%
Net Profit Margin
-1.31%
↑ 1.95%
Q3 FY22Q/Q Change
Revenue
597.9M
↑ 6.57%
Net Income
-13.2M
↑ 76.72%
Net Profit Margin
-2.21%
↓ 0.88%
Q4 FY22Q/Q Change
Revenue
578.0M
↓ 3.32%
Net Income
-15.5M
↑ 17.63%
Net Profit Margin
-2.69%
↓ 0.48%
Q1 FY23Q/Q Change
Revenue
568.6M
↓ 1.62%
Net Income
-9.8M
↓ 36.84%
Net Profit Margin
-1.73%
↑ 0.96%
Q2 FY23Q/Q Change
Revenue
549.3M
↓ 3.4%
Net Income
-9.9M
↑ 1.24%
Net Profit Margin
-1.81%
↓ 0.08%
Q3 FY23Q/Q Change
Revenue
553.3M
↑ 0.73%
Net Income
7.2M
↓ 172.86%
Net Profit Margin
1.31%
↑ 3.12%
Q4 FY23Q/Q Change
Revenue
588.0M
↑ 6.27%
Net Income
-17.1M
↓ 336.9%
Net Profit Margin
-2.92%
↓ 4.23%
FY18Y/Y Change
Total Assets
1.6B
↑ 5.91%
Total Liabilities
321.7M
↑ 7.71%
FY19Y/Y Change
Total Assets
1.7B
↑ 6.75%
Total Liabilities
315.1M
↓ 2.05%
FY20Y/Y Change
Total Assets
1.8B
↑ 4.21%
Total Liabilities
261.4M
↓ 17.04%
FY21Y/Y Change
Total Assets
1.9B
↑ 6.64%
Total Liabilities
264.7M
↑ 1.26%
FY22Y/Y Change
Total Assets
4.5B
↑ 140.1%
Total Liabilities
2.4B
↑ 816.38%
FY23Y/Y Change
Total Assets
4.4B
↓ 3.04%
Total Liabilities
2.3B
↓ 7.04%
Q3 FY22Q/Q Change
Total Assets
4.5B
↓ 3.04%
Total Liabilities
2.4B
↓ 2.65%
Q4 FY22Q/Q Change
Total Assets
4.5B
↑ 1.46%
Total Liabilities
2.4B
↓ 0.49%
Q1 FY23Q/Q Change
Total Assets
4.5B
↓ 1.0%
Total Liabilities
2.4B
↓ 2.29%
Q2 FY23Q/Q Change
Total Assets
4.5B
↓ 0.17%
Total Liabilities
2.3B
↓ 0.93%
Q3 FY23Q/Q Change
Total Assets
4.4B
↓ 1.93%
Total Liabilities
2.3B
↓ 2.97%
Q4 FY23Q/Q Change
Total Assets
4.4B
↑ 0.04%
Total Liabilities
2.3B
↓ 1.03%
FY18Y/Y Change
Operating Cash Flow
160.2M
↑ 3.75%
Investing Cash Flow
-103.4M
↓ 61.27%
Financing Cash Flow
8.0M
↓ 118.09%
FY19Y/Y Change
Operating Cash Flow
101.9M
↓ 36.39%
Investing Cash Flow
-166.9M
↑ 61.45%
Financing Cash Flow
-10.9M
↓ 235.95%
FY20Y/Y Change
Operating Cash Flow
222.8M
↑ 118.56%
Investing Cash Flow
-98.1M
↓ 41.19%
Financing Cash Flow
-40.0K
↓ 99.63%
FY21Y/Y Change
Operating Cash Flow
267.5M
↑ 20.11%
Investing Cash Flow
-90.7M
↓ 7.59%
Financing Cash Flow
-16.9M
↑ 42075.0%
FY22Y/Y Change
Operating Cash Flow
-62.1M
↓ 123.22%
Investing Cash Flow
-1.9B
↑ 2005.56%
Financing Cash Flow
1.6B
↓ 9803.81%
Q3 FY22Q/Q Change
Operating Cash Flow
2.3M
↓ 103.76%
Investing Cash Flow
-12.5M
↑ 141.29%
Financing Cash Flow
2.5M
↓ 162.78%
Q4 FY22Q/Q Change
Operating Cash Flow
-1.7M
↓ 174.1%
Investing Cash Flow
-24.0M
↑ 91.55%
Financing Cash Flow
-10.4M
↓ 510.47%
Q1 FY23Q/Q Change
Operating Cash Flow
41.2M
↓ 2510.58%
Investing Cash Flow
-15.2M
↓ 36.73%
Financing Cash Flow
-15.8M
↑ 52.5%
Q2 FY23Q/Q Change
Operating Cash Flow
-1.5M
↓ 103.57%
Investing Cash Flow
-17.6M
↑ 15.96%
Financing Cash Flow
-5.9M
↓ 62.76%

Technicals Summary

Sell

Neutral

Buy

Icu Medical Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Icu Medical Inc
Icu Medical Inc
0.12%
-11.55%
-43.69%
-52.85%
-58.16%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-2.9%
40.36%
43.11%
43.45%
100.14%
Resmed Inc.
Resmed Inc.
-2.2%
31.59%
-17.56%
-8.98%
80.27%
Becton, Dickinson And Company
Becton, Dickinson And Company
-0.65%
-9.46%
-8.24%
-8.8%
-4.48%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-1.97%
-1.51%
4.84%
22.21%
225.06%
Alcon Ag
Alcon Ag
-4.35%
6.39%
14.92%
9.65%
45.79%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Icu Medical Inc
Icu Medical Inc
356.69
NA
0.99
4.73
-0.01
0.01
NA
87.96
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
77.54
77.54
7.19
6.25
0.15
0.08
NA
37.77
Resmed Inc.
Resmed Inc.
32.03
32.03
1.88
7.41
0.22
0.11
0.01
30.47
Becton, Dickinson And Company
Becton, Dickinson And Company
55.27
55.27
1.34
12.95
0.05
0.03
0.02
87.68
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
49.53
49.53
6.9
7.62
0.21
0.12
0.0
39.2
Alcon Ag
Alcon Ag
42.12
42.12
4.62
3.06
0.05
0.02
0.0
41.81
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Icu Medical Inc
Icu Medical Inc
Buy
$2.4B
-58.16%
356.69
-1.31%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$137.7B
100.14%
77.54
25.24%
Resmed Inc.
Resmed Inc.
Buy
$28.5B
80.27%
32.03
19.77%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$69.6B
-4.48%
55.27
6.44%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$28.5B
225.06%
49.53
20.12%
Alcon Ag
Alcon Ag
Buy
$40.7B
45.79%
42.12
10.3%

Institutional Holdings

  • HHG PLC

    10.84%
  • BlackRock Inc

    10.60%
  • Vanguard Group Inc

    10.11%
  • Wellington Management Company LLP

    6.53%
  • Fuller & Thaler Asset Management Inc

    6.10%
  • JPMorgan Chase & Co

    3.06%

Company Information

icu medical is in the business of making connections -- human connections. we design and make some of the world's safest, most reliable medical devices and systems for infusion therapy, oncology, and critical care applications. our products improve patient outcomes by helping prevent bloodstream infections and protecting patients and healthcare workers from exposure to infectious diseases or hazardous drugs. our complete product line includes needlefree vascular access devices, custom infusion systems, closed delivery systems for hazardous drugs, advanced sensor catheters and hemodynamic monitoring systems. together, we help forge the human and emotional connections that are a vital link between patients and caregivers, that enhance clinical experience, and are the essence of outstanding quality-of-care. icu medical is headquartered in san clemente, california.

Organization
Icu Medical Inc
Employees
14000
CEO
Mr. Vivek Jain
Industry
Health Technology

FAQs